SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

WuXi AppTec Co., Ltd. WUXAY OTC

Other OTC • Healthcare • Medical - Diagnostics & Research • CN • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

WuXi AppTec Co., Ltd. (WUXAY) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $15.75. It has a SharesGrow Score of 91/100, indicating a strong investment profile with 6 out of 7 criteria passed.

Financials: revenue is $45.5B, +5.2%/yr average growth. Net income is $19.2B, growing at +36.7%/yr. Net profit margin is 42.1% (strong). Gross margin is 47.6% (+10.3 pp trend).

Balance sheet: total debt is $8.3B against $79.7B equity (Debt-to-Equity (D/E) ratio 0.1, conservative). Current ratio is 3.21 (strong liquidity). Debt-to-assets is 8%. Total assets: $103.1B.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 83/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 77/100 (Pass), Future ?/100 (Fail), Income 100/100 (Pass).

WUXAY SharesGrow Score Overview

93/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 83/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 77/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 100/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — WUXAY

WUXAY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

WUXAY: +5.2%/yr revenue is, +36.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

WUXAY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet WUXAY: Debt-to-Equity (D/E) ratio 0.1 (conservative), Current ratio is 3.21 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

WUXAY: Gross margin is 47.6% (+10.3 pp trend), $45B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 77/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

WUXAY: Net profit margin is 42.1%. strong (≥30%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range5.73-16.35

Volume100

Avg Volume (30D)1.36K

Market Cap$45.02B

Beta (1Y)0.54

Dividend Yield$0.1000

Share Statistics

EPS (TTM)6.75

Shares Outstanding$2.84B

IPO Date2021-02-24

Employees39,414

CEOGe Li

Financial Highlights & Ratios

Revenue (TTM)$45.46B

Gross Profit$21.65B

EBITDA$27.69B

Net Income$19.15B

Operating Income$17B

Total Cash$40.94B

Total Debt$8.26B

Net Debt$-26.87B

Total Assets$103.12B

Price / Earnings (P/E)2.3

Price / Sales (P/S)0.99

Analyst Forecast

Company Info

CountryCN

ExchangeOther OTC

CurrencyUSD

ISINUS98260P1030

Price Chart

WUXAY

WuXi AppTec Co., Ltd. ↗ · Other OTC

Healthcare • Medical - Diagnostics & Research

5.73 52WK RANGE 16.35

People Also View

IQVIA Holdings Inc.

Mettler-Toledo International Inc.

ICON Public Limited Company

Charles River Laboratories International, Inc.

Syneos Health, Inc.

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message